Prior studies have found that FXR disruption and activated TGR5 in the intestine, which are closely associated with intestinal BA signaling and nutrient homeostasis, produce an anti-obesity effect and improve glucose metabolism (18–22). This evidence concerns the gene GPBAR1 and obesity due to melanocortin 4 receptor deficiency.